Open the filing on EDGARThe Vita Coco Company Reports Second Quarter 2026 Financial Results and Raises Full Year Guidance
Net Sales were $216 million, an increase of 28%, driven by Vita Coco Coconut Water growth of 21%
Net Income Increased $27 million to $49 million and Non-GAAP Adjusted EBITDA Increased $38 million to $67 million
Raises Fiscal Year 2026 Guidance for Net Sales to between $790 million and $805 million and Adjusted EBITDA to between $154 million and $161 million
NEW YORK, NY - July 23, 2026 - The Vita Coco Company, Inc. (NASDAQ:COCO) (“Vita Coco” or “the Company”), a leading high-growth platform of better-for-you beverage brands, today announced financial results for the second quarter ended June 30, 2026.
Second Quarter and Year-to-Date 2026 Highlights Compared to Prior Year Period
- Net sales were $216 million, an increase of $47 million, or 28%, in the second quarter and $396 million year-to-date, an increase of $96 million, or 32%.
- Vita Coco Coconut Water net sales grew 21% in the second quarter and 29% year-to-date.
- Gross profit was $105 million in the second quarter, an increase of $44 million, and $177 million year-to-date, an increase of $68 million.
- Gross margin was 49% of net sales in the second quarter compared to 36%, and 45% of net sales year-to-date compared to 36%, with tariff refunds delivering a 700 basis point benefit to gross margin in the second quarter and 300 basis point benefit year-to-date.
- Net income was $49 million in the second quarter compared to $23 million, an increase of $27 million, and $80 million year-to-date compared to $42 million, an increase of $38 million.
- Net income per diluted share was $0.82 in the second quarter compared to $0.38, and $1.32 per diluted share year-to-date compared to $0.70.
- Non-GAAP Adjusted EBITDAwas $67 million in the second quarter compared to $29 million, an increase of $38 million. Non-GAAP Adjusted EBITDAwas $106 million year-to-date, compared to $52 million, an increase of $54 million.
Michael Kirban, the Company's Co-Founder and Executive Chairman, stated, "The coconut water category maintained very strong growth during the quarter, and continues to be one of the fastest growing beverage categories in our major markets. The growth is being generated by increases in both household penetration and in average consumption per household. I believe this growth is being driven by our investments in consumer education, emphasizing the fact that coconut water has 3.5 times the electrolytes of the leading sports drink while also offering an array of diverse usage and drinking occasions. I am very proud of our team's accomplishments and confident in our plans to maintain this growth and our category leadership well into the future. The global momentum in our category and our brand health and supply chain performance has me very excited for our long-term potential."
Martin Roper, the Company’s Chief Executive Officer, said, “Our healthy second quarter shipment performance was driven by robust branded retail growth in all our major markets, reflective of strong brand demand and by private label shipment strength mainly due to distribution gains. We are raising our full year Net Sales and Adjusted EBITDA guidance based on expected continued brand strength in our major markets coupled with strong second half private label shipment trends, and slight underlying gross margin improvement versus prior guidance. While we still expect to see current cost pressures temporarily reduce gross margin for the balance of year, our strong underlying performance allows us to increase our investments in sales and marketing in the second half in order to maintain our momentum into 2027."
Second Quarter 2026 Consolidated Results
Net sales increased $47 million, or 28%, to $216 million for the second quarter ended June 30, 2026, compared to $169 million in the prior year period. The increase in net sales was driven by case equivalent ("CE") volume gains of 15% for Vita Coco Coconut Water and 78% for Private Label as well as improved net pricing due to last year's price increases and favorable promotional timing.
Gross profit increased to $105 million, from $61 million in the prior year period driven by the recognition of tariff refunds, higher sales, favorable pricing, alongside lower ocean freight and finished goods costs, partially offset by slightly higher domestic logistics costs. Gross margin was 49% compared to 36% in the prior year period. The increase resulted primarily from the tariff refunds, higher net pricing alongside lower ocean freight rates and finished goods costs, slightly offset by higher domestic transportation costs.
Selling, general and administrative ("SG&A") expenses were $42 million, compared to $36 million in the prior year period. The increase was primarily driven by higher people-related costs reflecting increased incentive compensation, headcount growth, and stock-based compensation, as well as investments in sales and marketing.
Net income was $49 million, or $0.82 per diluted share, compared to net income of $23 million, or $0.38 per diluted share, in the prior year period. Net income benefited from higher gross profit, partially offset by higher SG&A spending and increased income tax expense.
Non-GAAP Adjusted EBITDA was $67 million, compared to $29 million in the prior year due to the increased gross profit partially offset by higher SG&A expenses.
Balance Sheet
As of June 30, 2026, the Company's financial position remained strong with no debt and $279 million in cash and cash equivalents, an increase from $197 million at the beginning of the year. Our inventory levels decreased to $83 million, down from $111 million as of December 31, 2025, due to strong year-to-date shipments. Accounts receivable increased to $132 million from $82 million as of prior year end, primarily reflecting growth in gross sales in 2026.
As of June 30, 2026, the Company had repurchased approximately $44 million of its common stock under its share repurchase program and had $21 million remaining under the existing authorization. During the six months ended June 30, 2026, and year to date through July 22, 2026, the Company repurchased $20 million of its common stock. On July 21, 2026, the Board approved an additional $40 million authorization, increasing the total authorized amount under the program to $105 million.
Acquisition of Copra, Inc.
On July 22, 2026, the Company issued a press release announcing that the Company acquired Copra, Inc. ("Copra"), one of the leading producers of super-premium Thai Nam Hom coconut water.
Fiscal Year 2026 Full Year Outlook
The Company is increasing its full year 2026 guidance, which includes balance of year for Copra, as follows:
- Net sales expected to be between $790 million and $805 million, driven by high teens to twenty percent growth of Vita Coco Coconut Water and strong Private Label trends from new and regained business. (Prior guidance was between $720 million and $735 million).
- Gross margin expected to be approximately 40% with benefit relative to prior year from tariff refunds, higher pricing and lower ocean freight partially offset by increased product costs and adverse product mix. (Prior guidance was 38%).
- Expect to deliver SG&A leverage of one percentage point of sales vs. 2025. (Prior guidance high single digit percentage growth).
- Adjusted EBITDA expected to be in the range of $154 million to $161 million. (Prior guidance was between $132 million and $138 million).
Uncertainty and instability in the current operating environment, geopolitical landscape, and global economies, including the military conflict in Iran and related impacts, changes in tariff rates, natural disasters, associated potential competitive pricing actions and our own price elasticity, could affect this outlook and our future results.
Footnotes
(1)Adjusted EBITDA represents earnings before interest, taxes, depreciation, and amortization as adjusted for certain items as set forth in the reconciliation table of U.S. GAAP to non-GAAP information and is a measure calculated and presented on the basis of methodologies other than in accordance with GAAP. Please refer to the Non-GAAP Financial Measures herein for further discussion and reconciliation of this measure to GAAP measures.
(2)GAAP Net income 2026 outlook is not provided due to the inherent difficulty in quantifying certain amounts due to a variety of factors including the unpredictability in the movement in foreign currency rates, as well as future charges or reversals outside of the normal course of business.
Conference Call and Webcast Details
To participate in the live earnings call and question and answer session, please register at https://register-conf.media-server.com/register/BIeb66856a8514488b970c774b5cc0004d and dial-in information will be provided directly to you. The live audio webcast will be accessible in the “Events” section of the Company’s Investor Relations website at https://investors.thevitacococompany.com/. An archived replay of the webcast will be available shortly after the live event has concluded.
About The Vita Coco Company
The Vita Coco Company is a family of brands on a mission to reimagine what’s possible when brands deliver healthy, nutritious, and great tasting products that are better for consumers and better for the world. This includes its flagship coconut water brand Vita Coco, and protein-infused water PWR LIFT. The Company was co-founded in 2004 by Michael Kirban and Ira Liran and is a public benefit corporation and Certified B Corporation. Vita Coco, the principal brand within the Company’s portfolio, is the leading coconut water brand in the U.S. With electrolytes, nutrients, and vitamins, coconut water has become a top beverage choice among consumers after a workout, in smoothies, as a cocktail mixer, after a night out, and more.
Non-GAAP Financial Measures
In addition to disclosing results determined in accordance with U.S. GAAP, the Company also discloses certain non-GAAP results of operations, including, but not limited to, Adjusted EBITDA, that include certain adjustments or exclude certain charges and gains that are described in the reconciliation table of U.S. GAAP to non-GAAP information provided at the end of this release. These non-GAAP measures are a key metric used by management and our board of directors to assess our financial performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance and because we believe it is useful for investors to see the measures that management uses to evaluate the Company. In addition, we believe the presentation of these measures is useful to investors for period-to-period comparisons of results as the items described below in the reconciliation tables do not reflect ongoing operating performance.
These measures are not in accordance with, or an alternative to, U.S. GAAP, and may be different from non-GAAP measures used by other companies. In addition, other companies, including companies in our industry, may calculate such measures differently, which reduces their usefulness as a comparative measure. Investors should not rely on any single financial measure when evaluating our business. This information should be considered as supplemental in nature and is not meant as a substitute for our operating results in accordance with U.S. GAAP. We recommend investors review the U.S. GAAP financial measures included in this earnings release. When viewed in conjunction with our U.S. GAAP results and the accompanying reconciliations, we believe these non-GAAP measures provide greater transparency and a more complete understanding of factors affecting our business than U.S. GAAP measures alone.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding our future financial and operating performance, including our GAAP and non-GAAP guidance, our strategy, projected costs, tariffs, prospects, expectations, plans, objectives of management, supply chain predictions, customer and supplier relationships, expected impact of acquisitions, and expected net sales and category share growth.
Forward-looking statements notice
The forward-looking statements in this release are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond the Company’s control. These factors include, but are not limited to, those discussed under the caption “Risk Factors” in our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and our other filings with the U.S. Securities and Exchange Commission ("SEC") as such factors may be updated from time to time and which are accessible on the SEC’s website at www.sec.gov and the Investor Relations page of our website at https://investors.thevitacococompany.com. Any forward-looking statements contained in this press release speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. We disclaim any obligation or undertaking to update or revise any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.
Website Disclosure
We intend to use our websites, vitacoco.com and investors.thevitacococompany.com, as a means for disclosing material non-public information and for complying with the SEC's Regulation FD and other disclosure obligations.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands, except share data)
| June 30, 2026 | December 31, 2025 |
|---|
| Assets | | |
| Current assets: | | |
| Cash and cash equivalents | $278,640 | $196,873 |
| Accounts receivable, net of allowance of $2,285 at June 30, 2026, and $2,660 at December 31, 2025 | 132,312 | 81,514 |
| Inventory | 82,911 | 111,468 |
| Supplier advances, current | 452 | 693 |
| Derivative assets | 2,940 | 732 |
| Prepaid expenses and other current assets | 37,775 | 30,160 |
| Total current assets | 535,030 | 421,440 |
| Property and equipment, net | 8,931 | 9,298 |
| Goodwill | 7,791 | 7,791 |
| Supplier advances, long-term | 1,692 | 1,860 |
| Deferred tax assets, net | 6,466 | 6,463 |
| Right-of-use assets, net | 10,643 | 11,592 |
| Other assets | 2,389 | 2,714 |
| Total assets | $572,942 | $461,158 |
| Liabilities and Stockholders’ Equity | | |
| Current liabilities: | | |
| Accounts payable | $30,975 | $25,464 |
| Accrued expenses and other current liabilities | 127,330 | 89,461 |
| Derivative liabilities | 1,121 | 1,507 |
| Total current liabilities | 159,426 | 116,432 |
| Operating lease liability, long-term | 12,520 | 13,087 |
| Other long-term liabilities | 92 | 97 |
| Total liabilities | $172,038 | $129,616 |
| Stockholders’ equity: | | |
| Common stock, $0.01 par value; 500,000,000 shares authorized; 64,900,349 and 64,186,549 shares issued at June 30, 2026 and December 31, 2025, respectively; 57,397,082 and 57,082,173 shares outstanding at June 30, 2026 and December 31, 2025, respectively. | 649 | 642 |
| Additional paid-in capital | 195,611 | 185,400 |
| Retained earnings | 307,939 | 228,014 |
| Accumulated other comprehensive gain (loss) | (287) | 486 |
| Treasury stock, 7,503,267 shares at cost as of June 30, 2026, and 7,104,376 as of December 31, 2025. | (103,008) | (83,000) |
| Total stockholders’ equity | 400,904 | 331,542 |
| Total liabilities and stockholders’ equity | $572,942 | $461,158 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except for share and per share data)
| Three Months Ended June 30, | Six Months Ended June 30, |
|---|
| 2026 | 2025 | 2026 | 2025 |
|---|
| Net sales | $216,153 | | $168,759 | | $395,918 | | $299,680 | |
| Cost of goods sold | 110,842 | | 107,494 | | 218,794 | | 190,330 | |
| Gross profit | 105,311 | | 61,265 | | 177,124 | | 109,350 | |
| Operating expenses | | | | |
| Selling, general and administrative | 42,172 | | 36,143 | | 80,403 | | 64,935 | |
| Income from operations | 63,139 | | 25,122 | | 96,721 | | 44,415 | |
| Other income (expense) | | | | |
| Unrealized (loss) gain on derivative instruments | (233) | | 1,067 | | 2,594 | | 3,884 | |
| Foreign currency (loss) gain | (1,046) | | 482 | | (1,545) | | 1,062 | |
| Interest income, net | 2,483 | | 1,500 | | 4,021 | | 3,018 | |
| Other income, net | 14 | | - | | 8 | | 155 | |
| Total other income | 1,218 | | 3,049 | | 5,078 | | 8,119 | |
| Income before income taxes | 64,357 | | 28,171 | | 101,799 | | 52,534 | |
| Income tax expense | 14,906 | | 5,263 | | 21,874 | | 10,744 | |
| Net income | $49,451 | | $22,908 | | $79,925 | | $41,790 | |
| Net income attributable to The Vita Coco Company, Inc. per common share | | | | |
| Basic | $0.86 | | $0.40 | | $1.40 | | $0.73 | |
| Diluted | $0.82 | | $0.38 | | $1.32 | | $0.70 | |
| Weighted-average number of common shares outstanding | | | | |
| Basic | 57,251,361 | | 56,795,499 | | 57,183,296 | | 56,894,274 | |
| Diluted | 60,642,797 | | 59,643,348 | | 60,390,598 | | 59,809,039 | |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
| Six Months Ended June 30, |
|---|
| 2026 | 2025 |
|---|
| Cash flows from operating activities: | | |
| Net income | $79,925 | | $41,790 | |
| Adjustments to reconcile net income to net cash provided by operating activities: | | |
| Depreciation and amortization | 965 | | 408 | |
| Amortization of debt issuance cost | 9 | | 6 | |
| (Decrease) increase of provision for credit losses | (829) | | 608 | |
| Unrealized (gain) on derivative instruments | (2,594) | | (3,884) | |
| Stock-based compensation | 8,216 | | 5,148 | |
| Noncash lease expense | 935 | | 747 | |
| Changes in operating assets and liabilities: | | |
| Accounts receivable | (50,590) | | (37,758) | |
| Inventory | 28,309 | | 127 | |
| Prepaid expenses, net supplier advances, and other assets | (7,175) | | (1,454) | |
| Accounts payable, accrued expenses, and other liabilities | 39,358 | | 6,272 | |
| Net cash provided by operating activities | 96,529 | | 12,010 | |
| Cash flows from investing activities: | | |
| Cash paid for property and equipment | (612) | | (1,508) | |
| Net cash used in investing activities | (612) | | (1,508) | |
| Cash flows from financing activities: | | |
| Proceeds from exercise of stock awards | 6,112 | | 977 | |
| Cash paid on notes payable | (3) | | (5) | |
| Cash paid to acquire treasury stock | (20,008) | | (10,053) | |
| Net cash used in financing activities | (13,899) | | (9,081) | |
| Effects of exchange rate changes on cash and cash equivalents | (246) | | 961 | |
| Net increase in cash and cash equivalents | 81,772 | | 2,382 | |
| Cash, cash equivalents and restricted cash at beginning of the period (1) | 198,154 | | 165,933 | |
| Cash, cash equivalents and restricted cash at end of the period (1) | $279,926 | | 168,315 | |
Includes $1,281 and $1,264 of restricted cash as of December 31, 2025 and 2024, respectively. Includes $1,286 and $1,273 of restricted cash as of June 30, 2026 and 2025, respectively, reported in other current assets on the condensed consolidated balance sheet.
RECONCILIATION FROM GAAP NET INCOME TO NON-GAAP ADJUSTED EBITDA
| Three Months Ended June 30, | Six Months Ended June 30, |
|---|
| 2026 | 2025 | 2026 | 2025 |
|---|
| (in thousands) | (in thousands) |
|---|
| Net income | 49,451 | | 22,908 | | $79,925 | | $41,790 | |
| Depreciation and amortization | 489 | | 206 | | 965 | | 408 | |
| Interest income, net | (2,483) | | (1,500) | | (4,021) | | (3,018) | |
| Income tax expense | 14,906 | | 5,263 | | 21,874 | | 10,744 | |
| EBITDA | $62,363 | | $26,877 | | $98,743 | | $49,924 | |
| Stock-based compensation (a) | 3,590 | | 2,962 | | 8,216 | | 5,148 | |
| Unrealized loss (gain) on derivative instruments (b) | 233 | | (1,067) | | (2,594) | | (3,884) | |
| Foreign currency loss (gain) (b) | 1,046 | | (482) | | 1,545 | | (1,062) | |
| Other adjustments (c) | - | | 952 | | - | | 1,621 | |
| Adjusted EBITDA | $67,232 | | $29,242 | | $105,910 | | $51,747 | |
(a)Non-cash charges related to stock-based compensation, which vary from period to period depending on volume and vesting timing of awards and forfeitures. We adjusted for these charges to facilitate comparison from period to period.
(b)Unrealized gains or losses on derivative instruments and foreign currency gains or losses are not considered in our evaluation of our ongoing performance.
(c)The three and six months ended June 30, 2025 included $0.6 million and $1.2 million, respectively, related to a one-time incentive program established in 2023 and measured based on full-year 2025 performance, and $0.4 million and $0.7 million, respectively, of overlapping rent expense associated with our new New York City office. The six-month period was partially offset by $0.1 million of partial recoveries of prepaid inventory from a supplier (refer to the Form 10-K for further details) and a $0.2 million gain from a sale of intellectual property.
SUPPLEMENTAL INFORMATION
| NET SALES |
|---|
| Three Months Ended June 30, | Six Months Ended June 30, |
|---|
| (in thousands) | | 2026 | | 2025 | | 2026 | | 2025 |
| Americas segment | | | | |
| Vita Coco Coconut Water | $137,921 | | $120,450 | | $255,954 | | $206,568 | |
| Private Label | | 26,901 | | 14,685 | | 51,301 | | 35,882 |
| Other | | 7,643 | | 6,826 | | 13,374 | | 12,111 |
| Subtotal | | $172,465 | | $141,961 | | $320,629 | | $254,561 |
| International segment | | | | |
| Vita Coco Coconut Water | | $31,763 | | $19,882 | | $54,283 | | $33,059 |
| Private Label | | 11,328 | | 6,222 | | 20,165 | | 10,981 |
| Other | | 597 | | 694 | | 841 | | 1,079 |
| Subtotal | | $43,688 | | $26,798 | | $75,289 | | $45,119 |
| Total net sales | | $216,153 | | $168,759 | | $395,918 | | $299,680 |
| COST OF GOODS SOLD & GROSS PROFIT |
|---|
| Three Months Ended June 30, | Six Months Ended June 30, |
|---|
| (in thousands) | | 2026 | | 2025 | | 2026 | | 2025 |
| Cost of goods sold | | | | |
| Americas segment | | $83,185 | | $90,915 | | $170,415 | | $161,203 |
| International segment | | 27,657 | | 16,579 | | 48,379 | | 29,127 |
| Total cost of goods sold | | $110,842 | | $107,494 | | $218,794 | | $190,330 |
| Gross profit | | | | |
| Americas segment | | $89,281 | | $51,046 | | $150,215 | | $93,358 |
| International segment | | 16,030 | | 10,219 | | 26,909 | | 15,992 |
| Total gross profit | | $105,311 | | $61,265 | | $177,124 | | $109,350 |
| Gross margin | | | | |
| Americas segment | 51.8% | | 36.0% | | 46.9% | | 36.7% | |
| International segment | 36.7% | | 38.1% | | 35.7% | | 35.4% | |
| Consolidated | 48.7% | | 36.3% | | 44.7% | | 36.5% | |
| VOLUME (CE) |
|---|
| Percentage Change - Three Months Ended June 30, 2026 vs. 2025 |
|---|
| Americas segment | International segment | Total |
|---|
| Vita Coco Coconut Water | 6.6% | 60.3% | 15.0% |
| Private Label | 81.7% | 71.0% | 78.1% |
| Other | 4.7% | (78.5)% | 1.9% |
| Subtotal | 16.1% | 62.2% | 24.3% |
| Percentage Change - Six Months Ended June 30, 2026 vs. 2025 |
| Americas segment | International segment | Total |
| Vita Coco Coconut Water | 16.0% | 53.7% | 22.1% |
| Private Label | 44.1% | 66.9% | 50.2% |
| Other | 8.8% | (33.5)% | 7.4% |
| Subtotal | 20.5% | 57.0% | 26.9% |
Note: A CE is a standard volume measure used by management which is defined as a case of 12 bottles of 330ml liquid beverages or the same liter volume of oil. We may have immaterial sales of raw materials at times that are treated as zero CEs for the purposes of these calculations.
Contacts
ICR, Inc.
investors@thevitacococompany.com